Use of Virtual Reality in Pain Management in Pediatric Oncology

Recruiting now · Not applicable

Conditions studied: Pediatric Tumor

In brief

DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.

Key facts

Study ID

NCT05592132

Run by

Centre Hospitalier Universitaire de la Réunion

People needed

74

Starts

2023-01-17

Expected to finish

2026-05-01

Last updated by the study team

2026-03-13

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patient who tolerates the virtual reality headset
• patient followed in pediatric oncology
• patient with a diagnosis of benign tumor or cancer
• patient who needs to have painful medical procedure during their treatment
• patient whose parents have signed the informed consent
• patient affiliated with social security or equivalent

You may not qualify if…

• patient with visual or hearing impairement
• patient with epilepsy or other neurological disease
• patient with psychiatric disease

Where it is running

• CHU de La Réunion — Saint-Denis, Reunion (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.